|
humans |
28 |
|
female |
25 |
|
male |
24 |
|
middle aged |
20 |
|
aged |
19 |
|
immunohistochemistry |
19 |
|
adult |
18 |
|
in situ hybridization |
16 |
|
hong kong |
11 |
|
base sequence |
9 |
|
molecular sequence data |
9 |
|
polymerase chain reaction |
9 |
|
aged, 80 and over |
8 |
|
animals |
8 |
|
chromosome aberrations |
8 |
|
epstein-barr virus |
8 |
|
gene amplification |
8 |
|
gene expression |
8 |
|
herpesvirus 4, human - isolation & purification |
8 |
|
immunoenzyme techniques |
8 |
|
rna, viral - analysis |
8 |
|
transcription, genetic |
8 |
|
dna mutational analysis |
7 |
|
epidermal growth factor receptor |
7 |
|
medical sciences |
7 |
|
mutation |
7 |
|
non-small-cell lung cancer |
7 |
|
pregnancy |
7 |
|
prognostic factors |
7 |
|
rna, messenger - metabolism |
7 |
|
tyrosine kinase inhibitors |
7 |
|
blotting, northern |
6 |
|
cell line, tumor |
6 |
|
child |
6 |
|
gene expression regulation, neoplastic |
6 |
|
genes, p53 |
6 |
|
genes, p53 - genetics |
6 |
|
gestational trophoblastic disease |
6 |
|
p53 |
6 |
|
receptor, epidermal growth factor - genetics |
6 |
|
tomography, x-ray computed |
6 |
|
adenocarcinoma - genetics - pathology |
5 |
|
adrenalectomy |
5 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
5 |
|
apoptosis - drug effects |
5 |
|
body weight - drug effects |
5 |
|
carcinoma, non-small-cell lung - enzymology - genetics - pathology |
5 |
|
cell movement - drug effects |
5 |
|
cell transformation, neoplastic - genetics |
5 |
|
china - ethnology |
5 |
|
dexamethasone |
5 |
|
dexamethasone - pharmacology |
5 |
|
dna, neoplasm |
5 |
|
dna, neoplasm - analysis |
5 |
|
dna, neoplasm - genetics |
5 |
|
epigenesis, genetic - genetics |
5 |
|
evaluation studies as topic |
5 |
|
gene expression regulation, neoplastic - genetics |
5 |
|
genetic predisposition to disease - genetics |
5 |
|
gestational age |
5 |
|
glucocorticoid |
5 |
|
growth hormone - blood - metabolism |
5 |
|
hematologic neoplasms - genetics |
5 |
|
hydatidiform mole - genetics - pathology |
5 |
|
hypothalamus |
5 |
|
hypothalamus - drug effects - metabolism |
5 |
|
leukemia, lymphocytic, chronic, b-cell - genetics |
5 |
|
lung neoplasms - enzymology - genetics - pathology |
5 |
|
lymphoma |
5 |
|
lymphoma - genetics |
5 |
|
micrornas - genetics |
5 |
|
microsatellite instability |
5 |
|
microsatellite repeats |
5 |
|
microsatellite repeats - genetics |
5 |
|
mutation - genetics |
5 |
|
neoplasm invasiveness |
5 |
|
paraventricular hypothalamic nucleus - drug effects - metabolism |
5 |
|
periventricular nucleus |
5 |
|
phosphorylation - drug effects |
5 |
|
placenta - anatomy & histology |
5 |
|
point mutation |
5 |
|
protein kinase inhibitors - pharmacology |
5 |
|
proto-oncogene proteins - genetics |
5 |
|
quinazolines - pharmacology |
5 |
|
rats |
5 |
|
rats, sprague-dawley |
5 |
|
receptor, epidermal growth factor - antagonists & inhibitors - genetics - metabolism |
5 |
|
reproducibility of results |
5 |
|
retrospective studies |
5 |
|
rna, messenger - analysis |
5 |
|
rna, small interfering - genetics - metabolism |
5 |
|
somatostatin |
5 |
|
somatostatin - genetics |
5 |
|
src-family kinases - antagonists & inhibitors - metabolism |
5 |
|
uterine neoplasms - genetics - pathology |
5 |
|
adenocarcinoma |
4 |
|
alternative splicing |
4 |
|
antineoplastic agents - pharmacology |
4 |
|
bax |
4 |
|
bcl-2-associated x protein |
4 |
|
carcinoma |
4 |
|
carcinoma - genetics - pathology - virology |
4 |
|
carcinoma, hepatocellular - ethnology - genetics - pathology |
4 |
|
carcinoma, non-small-cell lung - drug therapy - genetics |
4 |
|
centromere |
4 |
|
chromosome |
4 |
|
chromosomes, human, pair 11 |
4 |
|
chromosomes, human, pair 12 |
4 |
|
chromosomes, human, pair 17 |
4 |
|
codon |
4 |
|
deoxyribonucleases, type ii site-specific |
4 |
|
disease transmission, infectious |
4 |
|
dna primers |
4 |
|
drug resistance, neoplasm |
4 |
|
endometrial neoplasms - genetics - pathology - ultrastructure |
4 |
|
endometrial stromal sarcoma |
4 |
|
ewing sarcoma |
4 |
|
fatal outcome |
4 |
|
gadolinium dtpa - diagnostic use |
4 |
|
gastric carcinoma |
4 |
|
gastrointestinal hemorrhage - etiology |
4 |
|
genes, ras |
4 |
|
genes, tumor suppressor - genetics |
4 |
|
glioma |
4 |
|
herpesviridae infections - complications |
4 |
|
herpesvirus 4, human - pathogenicity |
4 |
|
hong kong chinese |
4 |
|
immunoglobulin light chains - analysis |
4 |
|
in situ hybridization - methods |
4 |
|
interphase |
4 |
|
intestinal mucosa - pathology |
4 |
|
intestinal neoplasms - pathology - radiography |
4 |
|
intestine, small - pathology - radiography |
4 |
|
ki67 |
4 |
|
kidney transplantation - adverse effects |
4 |
|
liver neoplasms - ethnology - genetics - pathology |
4 |
|
lung |
4 |
|
lung neoplasms - drug therapy - genetics |
4 |
|
lung neoplasms - genetics - pathology |
4 |
|
lymphoma, b-cell - chemistry - etiology - genetics |
4 |
|
magnetic resonance imaging |
4 |
|
mdm2 |
4 |
|
mice |
4 |
|
multiple myeloma - pathology |
4 |
|
mutation, missense |
4 |
|
neoplasm proteins - genetics |
4 |
|
nucleic acid hybridization |
4 |
|
pelvis - pathology |
4 |
|
phosphorylation |
4 |
|
plasmacytoma - complications - pathology |
4 |
|
post- transplantation |
4 |
|
primitive neuroectodermal tumor |
4 |
|
protein biosynthesis |
4 |
|
proto-oncogene proteins c-bcl-2 |
4 |
|
receptors, transforming growth factor beta - genetics |
4 |
|
reverse transcriptase polymerase chain reaction |
4 |
|
sarcoma, endometrial stromal - genetics - pathology - ultrastructure |
4 |
|
sarcoma, ewing - pathology - radiography |
4 |
|
sequence analysis, dna |
4 |
|
small intestine |
4 |
|
stomach neoplasms - complications - pathology |
4 |
|
stomach neoplasms - genetics - pathology - virology |
4 |
|
tumor cells, cultured |
4 |
|
tumor virus infections - complications |
4 |
|
tyrosine |
4 |
|
tĪ²rii |
4 |
|
x chromosome |
4 |
|
y chromosome |
4 |
|
acute lymphoblastic leukemia |
3 |
|
adaptor proteins, signal transducing |
3 |
|
adenocarcinoma - diagnosis - genetics |
3 |
|
adenocarcinoma - enzymology - pathology |
3 |
|
adenocarcinoma - ethnology - genetics |
3 |
|
adenocarcinoma - etiology - genetics - pathology |
3 |
|
adenocarcinoma - genetics - metabolism - pathology |
3 |
|
adenocarcinoma - metabolism |
3 |
|
adenoma |
3 |
|
adenoma - enzymology - pathology |
3 |
|
adenoma - genetics - metabolism - pathology |
3 |
|
adenomatous polyposis coli - genetics - pathology |
3 |
|
adolescent |
3 |
|
age factors |
3 |
|
all |
3 |
|
allelic imbalance |
3 |
|
amino acid sequence |
3 |
|
amino acid substitution |
3 |
|
angiogenesis |
3 |
|
angiopoietin-1 |
3 |
|
angiopoietin-2 |
3 |
|
angiopoietins |
3 |
|
antibodies, monoclonal - administration & dosage |
3 |
|
antibodies, monoclonal, murine-derived |
3 |
|
antineoplastic agents - administration & dosage |
3 |
|
antineoplastic agents, alkylating - adverse effects - therapeutic use |
3 |
|
antirheumatic agents - administration & dosage - adverse effects |
3 |
|
array cgh |
3 |
|
arsenic |
3 |
|
arsenicals - therapeutic use |
3 |
|
asian continental ancestry group |
3 |
|
asian continental ancestry group - genetics |
3 |
|
astrocytoma - blood supply - genetics |
3 |
|
astrocytoma - blood supply - metabolism - pathology |
3 |
|
astrocytoma - metabolism - pathology |
3 |
|
autoimmune diseases |
3 |
|
autoimmune diseases - complications - drug therapy - metabolism |
3 |
|
azathioprine |
3 |
|
base pair mismatch |
3 |
|
base pair mismatch - genetics |
3 |
|
blotting, southern |
3 |
|
brain neoplasms - blood supply - genetics |
3 |
|
brain neoplasms - blood supply - metabolism - pathology |
3 |
|
brain neoplasms - genetics - metabolism - pathology |
3 |
|
brain neoplasms - genetics - pathology |
3 |
|
brain neoplasms - metabolism - pathology |
3 |
|
bronchi - cytology |
3 |
|
burkitt lymphoma - drug therapy - etiology - metabolism - virology |
3 |
|
burkitt lymphoma - drug therapy - genetics - pathology |
3 |
|
carcinoma - genetics |
3 |
|
carcinoma - genetics - metabolism - pathology |
3 |
|
carcinoma - metabolism - pathology - virology |
3 |
|
carcinoma - metabolism - virology |
3 |
|
carcinoma - pathology - virology |
3 |
|
carcinoma, hepatocellular - complications - ethnology - genetics |
3 |
|
carcinoma, non-small-cell lung - blood supply - metabolism |
3 |
|
carcinoma, non-small-cell lung - diagnosis - genetics |
3 |
|
carcinoma, non-small-cell lung - genetics - metabolism |
3 |
|
carcinoma, non-small-cell lung - genetics - pathology |
3 |
|
carcinoma, non-small-cell lung - metabolism |
3 |
|
carcinoma, non-small-cell lung - virology |
3 |
|
carcinoma, squamous cell - diagnosis - genetics |
3 |
|
carcinoma, squamous cell - ethnology - pathology - virology |
3 |
|
carcinoma, squamous cell - metabolism - pathology - virology |
3 |
|
carcinoma, squamous cell - virology |
3 |
|
carrier proteins |
3 |
|
cell differentiation |
3 |
|
cell line |
3 |
|
cell transformation, neoplastic - genetics - pathology |
3 |
|
cell transformation, neoplastic - metabolism |
3 |
|
cell transformation, viral - drug effects |
3 |
|
central nervous system neoplasms - chemistry - genetics - pathology |
3 |
|
cerebellar neoplasms - blood supply - genetics |
3 |
|
chemicals and cas registry numbers |
3 |
|
chemokine ccl2 - biosynthesis |
3 |
|
chemokine ccl2 - metabolism |
3 |
|
child, preschool |
3 |
|
china |
3 |
|
chinese people |
3 |
|
cholecystectomy |
3 |
|
chromosomal instability |
3 |
|
chromosome breakage |
3 |
|
chromosome deletion |
3 |
|
chromosomes, human, pair 16 - genetics |
3 |
|
chromosomes, human, pair 9 - genetics |
3 |
|
clonal evolution |
3 |
|
clonality |
3 |
|
clone cells |
3 |
|
codon - genetics |
3 |
|
colon |
3 |
|
colon - metabolism - pathology |
3 |
|
colon carcinoma |
3 |
|
colonic neoplasms - drug therapy - pathology |
3 |
|
colonic neoplasms - enzymology - pathology |
3 |
|
colonic neoplasms - genetics - metabolism - pathology |
3 |
|
colonic neoplasms - metabolism |
3 |
|
colorectal cancer |
3 |
|
colorectal neoplasms - ethnology - genetics |
3 |
|
colorectal neoplasms - genetics |
3 |
|
colorectal neoplasms - genetics - metabolism - pathology |
3 |
|
colorectal neoplasms - genetics - pathology |
3 |
|
colorectal neoplasms, hereditary nonpolyposis - genetics |
3 |
|
cyclin-dependent kinase inhibitor p15 - metabolism |
3 |
|
cyclin-dependent kinase inhibitor p16 - metabolism |
3 |
|
cyclophosphamide |
3 |
|
cystadenoma, papillary - complications - metabolism - pathology |
3 |
|
dedifferentiation |
3 |
|
diagnosis, differential |
3 |
|
diffuse large b-cell lymphoma |
3 |
|
disease progression |
3 |
|
dlbc |
3 |
|
dna methylation |
3 |
|
dna methylation - drug effects |
3 |
|
dna primers - chemistry |
3 |
|
dna repair - genetics |
3 |
|
dna, satellite - genetics |
3 |
|
dna-binding proteins |
3 |
|
eber |
3 |
|
ebna2 |
3 |
|
ebv proteins |
3 |
|
eef1a2 |
3 |
|
egfr |
3 |
|
eml4-alk |
3 |
|
endometrial neoplasms - genetics - pathology |
3 |
|
endothelial growth factors - biosynthesis |
3 |
|
endothelial growth factors - genetics - metabolism |
3 |
|
endothelial growth factors - genetics - physiology |
3 |
|
endothelial growth factors - metabolism |
3 |
|
ependymoma |
3 |
|
ependymoma - blood supply - metabolism - pathology |
3 |
|
epididymal cystadenoma |
3 |
|
epididymis - pathology |
3 |
|
epithelial cells - drug effects - metabolism - physiology |
3 |
|
epstein-barr virus infections - complications |
3 |
|
epstein-barr virus-expressed rna |
3 |
|
etoposide - adverse effects - therapeutic use |
3 |
|
european continental ancestry group - genetics |
3 |
|
exons |
3 |
|
eye neoplasms - pathology - virology |
3 |
|
flow cytometry |
3 |
|
flt-1 |
3 |
|
founder effect |
3 |
|
fusion gene |
3 |
|
gallbladder neoplasms - diagnosis - pathology - surgery |
3 |
|
gene deletion |
3 |
|
gene dosage |
3 |
|
genes, ras - genetics |
3 |
|
genome, human |
3 |
|
genome, viral |
3 |
|
germ-line mutation |
3 |
|
germline mutation |
3 |
|
gestational trophoblastic disease - drug therapy - pathology |
3 |
|
glioblastoma - genetics - pathology |
3 |
|
glioblastoma - metabolism - pathology |
3 |
|
glioma - chemistry - genetics - pathology |
3 |
|
glioma - metabolism - pathology |
3 |
|
haplotypes - genetics |
3 |
|
head and neck neoplasms - metabolism - virology |
3 |
|
hemangioblastoma |
3 |
|
hepatitis b - complications |
3 |
|
hepatocellular carcinoma |
3 |
|
herpesviridae infections |
3 |
|
herpesviridae infections - complications - genetics - pathology |
3 |
|
herpesviridae infections - complications - pathology |
3 |
|
herpesvirus 4, human - genetics |
3 |
|
herpesvirus 4, human - genetics - immunology - isolation & purification |
3 |
|
herpesvirus 4, human - genetics - isolation & purification - metabolism |
3 |
|
herpesvirus 4, human - immunology - isolation & purification |
3 |
|
herpesvirus 4, human - metabolism |
3 |
|
hmlh1 |
3 |
|
hnpcc |
3 |
|
hnpcc syndrome |
3 |
|
hong kong - ethnology |
3 |
|
igh |
3 |
|
immunoglobulin heavy chain |
3 |
|
immunophenotyping |
3 |
|
in situ hybridization, fluorescence |
3 |
|
intestinal mucosa - enzymology - pathology |
3 |
|
intestinal polyps - pathology |
3 |
|
intragenic deletion |
3 |
|
karyotyping |
3 |
|
kdr |
3 |
|
kif5b-alk |
3 |
|
klf6 |
3 |
|
lacrimal apparatus - pathology |
3 |
|
lacrimal apparatus diseases - pathology |
3 |
|
lacrimal sac |
3 |
|
large intestine |
3 |
|
leukemia, promyelocytic, acute - chemically induced - drug therapy - etiology |
3 |
|
liver neoplasms - complications - ethnology - genetics |
3 |
|
lmp-1 |
3 |
|
loss of heterozygosity |
3 |
|
lung adenocarcinoma |
3 |
|
lung carcinoma |
3 |
|
lung neoplasms - blood supply - metabolism |
3 |
|
lung neoplasms - diagnosis |
3 |
|
lung neoplasms - diagnosis - genetics |
3 |
|
lung neoplasms - etiology - genetics - pathology |
3 |
|
lung neoplasms - genetics - metabolism |
3 |
|
lung neoplasms - metabolism |
3 |
|
lung neoplasms - metabolism - pathology - virology |
3 |
|
lung neoplasms - virology |
3 |
|
lymphatic metastasis |
3 |
|
lymphoepithelial carcinoma |
3 |
|
lymphoepithelioma |
3 |
|
lymphoepithelioma-like carcinoma |
3 |
|
lymphoid tissue - pathology - virology |
3 |
|
lymphokines - biosynthesis |
3 |
|
lymphokines - genetics - metabolism |
3 |
|
lymphokines - genetics - physiology |
3 |
|
lymphokines - metabolism |
3 |
|
lymphoma, b-cell - drug therapy - genetics - pathology |
3 |
|
lymphoma, b-cell, marginal zone - diagnosis - pathology - surgery |
3 |
|
lymphoma, b-cell, marginal zone - drug therapy - pathology |
3 |
|
lymphoma, large b-cell, diffuse - drug therapy - genetics - pathology |
3 |
|
lymphoma, mantle-cell - drug therapy - pathology |
3 |
|
lymphoma, non-hodgkin - diagnosis |
3 |
|
lysozyme |
3 |
|
macrophage |
3 |
|
macrophages - pathology |
3 |
|
macrophages - physiology |
3 |
|
mantle cell lymphoma |
3 |
|
membrane glycoproteins - biosynthesis |
3 |
|
metaphase - genetics |
3 |
|
metaphase cgh |
3 |
|
methotrexate |
3 |
|
mice, transgenic |
3 |
|
microarray analysis - methods |
3 |
|
microglia |
3 |
|
mismatch repair gene mutation |
3 |
|
monocyte chemoattractant protein- 1 |
3 |
|
monocyte chemoattractant protein-1 |
3 |
|
mucoepidermoid carcinoma |
3 |
|
multivariate analysis |
3 |
|
muramidase - biosynthesis - genetics |
3 |
|
mutagenesis - drug effects |
3 |
|
mutations |
3 |
|
muts homolog 2 protein |
3 |
|
neoplasm proteins - biosynthesis |
3 |
|
neoplasm proteins - metabolism |
3 |
|
neoplasm staging |
3 |
|
neoplasms - epidemiology - genetics - pathology - virology |
3 |
|
neoplasms, second primary |
3 |
|
neoplasms, second primary - drug therapy - etiology |
3 |
|
neoplasms, second primary - genetics - pathology |
3 |
|
neoplastic syndromes, hereditary - genetics - pathology |
3 |
|
neovascularization, pathologic |
3 |
|
neovascularization, pathologic - metabolism |
3 |
|
nicotine - pharmacology |
3 |
|
non-small cell lung carcinoma |
3 |
|
non-smokers |
3 |
|
nonsmall cell lung cancer |
3 |
|
nonsmoker |
3 |
|
nose neoplasms - metabolism - pathology - virology |
3 |
|
nuclear proteins |
3 |
|
nucleic acid hybridization - methods |
3 |
|
obstetrics and gynecology |
3 |
|
oligodendroglioma |
3 |
|
oligodendroglioma - blood supply - metabolism - pathology |
3 |
|
oligonucleotide array sequence analysis |
3 |
|
oncogene proteins, fusion - genetics |
3 |
|
oncogene proteins, viral - genetics |
3 |
|
oncogenesis |
3 |
|
organ specificity |
3 |
|
overexpression |
3 |
|
oxides - therapeutic use |
3 |
|
p53 gene |
3 |
|
p53 mutation |
3 |
|
paraffin embedding |
3 |
|
paranasal sinus neoplasms - metabolism - pathology - virology |
3 |
|
parietal lobe |
3 |
|
pcr |
3 |
|
pedigree |
3 |
|
pilocytic astrocytoma |
3 |
|
ploidies |
3 |
|
polymerase chain reaction - methods |
3 |
|
polymorphism, single-stranded conformational |
3 |
|
precancerous conditions - genetics - metabolism - pathology |
3 |
|
prevalence |
3 |
|
promoter methylation |
3 |
|
promoter regions, genetic |
3 |
|
proteins - genetics |
3 |
|
proto-oncogene proteins - biosynthesis - genetics |
3 |
|
proto-oncogene proteins - metabolism |
3 |
|
random allocation |
3 |
|
receptor protein-tyrosine kinases - biosynthesis |
3 |
|
receptor protein-tyrosine kinases - metabolism |
3 |
|
receptor tyrosine kinase tie2 |
3 |
|
receptors, growth factor - genetics - physiology |
3 |
|
receptors, growth factor - metabolism |
3 |
|
receptors, mitogen - genetics - physiology |
3 |
|
receptors, nicotinic - biosynthesis - genetics |
3 |
|
receptors, vascular endothelial growth factor |
3 |
|
reference values |
3 |
|
ribosomal proteins - analysis |
3 |
|
rna - analysis |
3 |
|
rna, messenger - biosynthesis |
3 |
|
rna, messenger - biosynthesis - genetics |
3 |
|
rna, neoplasm - analysis |
3 |
|
rna, neoplasm - metabolism |
3 |
|
rna, viral - metabolism |
3 |
|
rna-binding proteins - analysis |
3 |
|
salivary gland |
3 |
|
sarcoma, endometrial stromal - genetics - pathology |
3 |
|
secondary apl |
3 |
|
sequence deletion |
3 |
|
sinonasal carcinoma |
3 |
|
smoking |
3 |
|
smoking - adverse effects - genetics |
3 |
|
smoking - adverse effects - genetics - metabolism |
3 |
|
solitary pulmonary nodule - diagnosis - genetics - virology |
3 |
|
spinal cord neoplasms - blood supply - genetics |
3 |
|
statistics, nonparametric |
3 |
|
stomach neoplasms - diagnosis - secondary |
3 |
|
stomach neoplasms - genetics |
3 |
|
stomach neoplasms - metabolism - virology |
3 |
|
syndrome |
3 |
|
t-lymphocytes - physiology |
3 |
|
tdt |
3 |
|
temporal lobe |
3 |
|
testicular neoplasms - complications - metabolism - pathology |
3 |
|
therapy-related lymphoma |
3 |
|
tissue distribution |
3 |
|
tobacco |
3 |
|
tobacco smoke pollution |
3 |
|
treatment outcome |
3 |
|
tretinoin - therapeutic use |
3 |
|
tumor suppressor protein p53 - analysis - genetics |
3 |
|
tumor suppressor protein p53 - biosynthesis |
3 |
|
tumor suppressor protein p53 - metabolism |
3 |
|
tumor virus infections |
3 |
|
tumour-associated macrophages |
3 |
|
turcot's syndrome |
3 |
|
undifferentiated carcinoma |
3 |
|
up-regulation |
3 |
|
vascular endothelial growth factor |
3 |
|
vascular endothelial growth factor a |
3 |
|
vascular endothelial growth factor receptor-1 |
3 |
|
vascular endothelial growth factor splice variants |
3 |
|
vascular endothelial growth factors |
3 |
|
vascular neoplasms - diagnosis |
3 |
|
vascular permeability factor |
3 |
|
vegf |
3 |
|
viral matrix proteins - genetics |
3 |
|
von hippel-lindau disease - complications - metabolism - pathology |
3 |
|
von hippel-lindau syndrome |
3 |
|
adenocarcinoma - genetics |
2 |
|
adenocarcinoma - pathology - virology |
2 |
|
africa |
2 |
|
aleutian mink disease virus |
2 |
|
allele-specific priming |
2 |
|
americas |
2 |
|
anaplastic lymphoma kinase |
2 |
|
antigens, cd20 - analysis |
2 |
|
antigens, cd5 - analysis |
2 |
|
asia |
2 |
|
b-lymphocytes - immunology |
2 |
|
carcinoma - genetics - microbiology - pathology |
2 |
|
carcinoma - microbiology - pathology |
2 |
|
carcinoma, squamous cell - microbiology - pathology |
2 |
|
carcinoma, squamous cell - pathology |
2 |
|
carcinoma, squamous cell - pathology - radiography - virology |
2 |
|
chromosome aberration |
2 |
|
chromosome in situ hybridization |
2 |
|
chromosomes, human, pair 3 - genetics |
2 |
|
cish |
2 |
|
colonic neoplasms - complications - pathology |
2 |
|
colorectal carcinoma |
2 |
|
colorectal neoplasms - epidemiology - genetics |
2 |
|
colorectal neoplasms - pathology - virology |
2 |
|
comparative genomic hybridization |
2 |
|
crizotinib |
2 |
|
dna, viral - analysis |
2 |
|
ear |
2 |
|
ear, middle |
2 |
|
epidemiology |
2 |
|
epithelial cells |
2 |
|
epithelium - virology |
2 |
|
europe |
2 |
|
exon 23 |
2 |
|
exon 27 |
2 |
|
exon skipping |
2 |
|
gallbladder - pathology |
2 |
|
gastric lymphoma |
2 |
|
gastritis - genetics - pathology |
2 |
|
genes, viral |
2 |
|
genetic variation |
2 |
|
genomic diversity |
2 |
|
hairy cell leukaemia |
2 |
|
herpesviridae infections - diagnosis |
2 |
|
herpesviridae infections - virology |
2 |
|
herpesvirus 4, human - genetics - isolation & purification |
2 |
|
herpesvirus 4, human - isolation & purification - physiology |
2 |
|
high resolution melting |
2 |
|
hong kong - epidemiology |
2 |
|
hong kong chinese population |
2 |
|
hpv-53 |
2 |
|
hpv-56 |
2 |
|
hpv-66 |
2 |
|
hypermethylation |
2 |
|
incidence |
2 |
|
interphase cytogenetics |
2 |
|
intestinal perforation - etiology |
2 |
|
kinase inhibitor |
2 |
|
latency |
2 |
|
leukaemia |
2 |
|
leukemia, lymphocytic, chronic, b-cell - immunology - pathology |
2 |
|
leukemic infiltration |
2 |
|
lung cancer |
2 |
|
lung neoplasms - genetics |
2 |
|
lung neoplasms - genetics - microbiology - pathology |
2 |
|
lymphocytes - virology |
2 |
|
lymphoma, b-cell - genetics - pathology |
2 |
|
lymphoma, b-cell, marginal zone - complications - pathology |
2 |
|
microrna |
2 |
|
nasal mucosa - virology |
2 |
|
nasopharynx |
2 |
|
nasopharynx - virology |
2 |
|
nonsmokers |
2 |
|
p53 mutations |
2 |
|
papillomaviridae - classification - genetics |
2 |
|
papillomaviridae - classification - genetics - pathogenicity |
2 |
|
papillomaviridae - genetics |
2 |
|
papillomavirus infections - virology |
2 |
|
peritonitis |
2 |
|
phylogeny |
2 |
|
sepsis |
2 |
|
sequencing |
2 |
|
stomach neoplasms - genetics - pathology |
2 |
|
stomach neoplasms - pathology - virology |
2 |
|
time factors |
2 |
|
tonsil neoplasm |
2 |
|
tonsillar neoplasms - microbiology - pathology |
2 |
|
trisomy |
2 |
|
trisomy 3 |
2 |
|
tumor virus infections - diagnosis |
2 |
|
tumour suppressor |
2 |
|
tyrosine kinase |
2 |
|
viral proteins - analysis |
2 |
|
virus latency |
2 |
|
virus replication |
2 |
|
antineoplastic agents, alkylating - therapeutic use |
1 |
|
bell palsy - complications |
1 |
|
bone marrow cells |
1 |
|
cervical smear |
1 |
|
chlorambucil - therapeutic use |
1 |
|
chloramphenicol o-acetyltransferase - biosynthesis - genetics |
1 |
|
cloning, molecular |
1 |
|
colitis, ulcerative - enzymology |
1 |
|
conjunctival diseases - complications |
1 |
|
crohn disease - enzymology |
1 |
|
cytokines - biosynthesis |
1 |
|
dna - genetics |
1 |
|
epithelium - enzymology |
1 |
|
epithelium - metabolism |
1 |
|
familial adenomatous polyposis |
1 |
|
functional laterality |
1 |
|
gene expression regulation - genetics |
1 |
|
genes |
1 |
|
genes, reporter |
1 |
|
granulocytes - metabolism |
1 |
|
infection - immunology |
1 |
|
inflammation - immunology |
1 |
|
inflammatory bowel diseases - enzymology - genetics - pathology |
1 |
|
intestinal mucosa - cytology - metabolism |
1 |
|
intestine, small - enzymology |
1 |
|
intestines - cytology |
1 |
|
liver - cytology |
1 |
|
lung - cytology |
1 |
|
lymphoma, b-cell, marginal zone - complications - drug therapy - pathology |
1 |
|
lymphoma-like lesions |
1 |
|
macrophage activation - genetics |
1 |
|
macrophages - enzymology |
1 |
|
macrophages - immunology |
1 |
|
macrophages, peritoneal - metabolism |
1 |
|
mice, inbred c57bl |
1 |
|
muramidase - genetics |
1 |
|
mycobacterium bovis |
1 |
|
nervous system - cytology |
1 |
|
pouch polyposis |
1 |
|
primary cervical lymphoma |
1 |
|
recombinant fusion proteins - biosynthesis - genetics |
1 |
|
repetitive sequences, nucleic acid |
1 |
|
rna, messenger - analysis - genetics |
1 |
|
rna, messenger - genetics |
1 |
|
skin - cytology |
1 |
|
spleen - cytology |
1 |
|
sulindac |
1 |
|
tuberculoma - enzymology - pathology |
1 |
|
tuberculosis, hepatic - enzymology - pathology |
1 |
|
tumor necrosis factor-alpha - genetics |
1 |
|
wounds and injuries - immunology |
1 |
